DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) today announced that it entered into securities purchase agreements with certain institutional investors in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE